Literature DB >> 25126385

Umbilical cord fibroblasts: Could they be considered as mesenchymal stem cells?

Mustapha Zeddou1, Biserka Relic1, Michel G Malaise1.   

Abstract

In cell therapy protocols, many tissues were proposed as a source of mesenchymal stem cells (MSC) isolation. So far, bone marrow (BM) has been presented as the main source of MSC despite the invasive isolation procedure related to this source. During the last years, the umbilical cord (UC) matrix was cited in different studies as a reliable source from which long term ex vivo proliferating fibroblasts were isolated but with contradictory data about their immunophenotype, gene expression profile, and differentiation potential. Hence, an interesting question emerged: Are cells isolated from cord matrix (UC-MSC) different from other MSCs? In this review, we will summarize different studies that isolated and characterized UC-MSC. Considering BM-MSC as gold standard, we will discuss if UC-MSC fulfill different criteria that define MSC, and what remain to be done in this issue.

Keywords:  Bone marrow; Cord matrix; Differentiation; Immunophenotype; Mesenchymal stem cells

Year:  2014        PMID: 25126385      PMCID: PMC4131277          DOI: 10.4252/wjsc.v6.i3.367

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  18 in total

1.  Distinct differentiation potential of "MSC" derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells?

Authors:  Julia Bosch; Amelie Pia Houben; Teja Falk Radke; Daniela Stapelkamp; Erich Bünemann; Percy Balan; Anja Buchheiser; Stefanie Liedtke; Gesine Kögler
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

2.  SSEA-4 identifies mesenchymal stem cells from bone marrow.

Authors:  Eun J Gang; Darko Bosnakovski; Camila A Figueiredo; Jan W Visser; Rita C R Perlingeiro
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

3.  Mesenchymal stem cells: revisiting history, concepts, and assays.

Authors:  Paolo Bianco; Pamela Gehron Robey; Paul J Simmons
Journal:  Cell Stem Cell       Date:  2008-04-10       Impact factor: 24.633

4.  Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord.

Authors:  Kiran Seshareddy; Deryl Troyer; Mark L Weiss
Journal:  Methods Cell Biol       Date:  2008       Impact factor: 1.441

5.  The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood.

Authors:  Mustapha Zeddou; Alexandra Briquet; Biserka Relic; Claire Josse; Michel G Malaise; André Gothot; Chantal Lechanteur; Yves Beguin
Journal:  Cell Biol Int       Date:  2010-07       Impact factor: 3.612

6.  CD105 protein depletion enhances human adipose-derived stromal cell osteogenesis through reduction of transforming growth factor β1 (TGF-β1) signaling.

Authors:  Benjamin Levi; Derrick C Wan; Jason P Glotzbach; Jeong Hyun; Michael Januszyk; Daniel Montoro; Michael Sorkin; Aaron W James; Emily R Nelson; Shuli Li; Natalina Quarto; Min Lee; Geoffrey C Gurtner; Michael T Longaker
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

7.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.

Authors:  Simón Méndez-Ferrer; Tatyana V Michurina; Francesca Ferraro; Amin R Mazloom; Ben D Macarthur; Sergio A Lira; David T Scadden; Avi Ma'ayan; Grigori N Enikolopov; Paul S Frenette
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

8.  Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration.

Authors:  Guo Li; Xiao-ai Zhang; Hua Wang; Xin Wang; Chun-ling Meng; Chu-yan Chan; David Tai Wai Yew; Kam Sze Tsang; Karen Li; Sau-na Tsai; Sai-ming Ngai; Zhong Chao Han; Marie Chia-mi Lin; Ming-liang He; Hsiang-fu Kung
Journal:  Proteomics       Date:  2009-01       Impact factor: 3.984

9.  Differential signalling through ALK-1 and ALK-5 regulates leptin expression in mesenchymal stem cells.

Authors:  Mustapha Zeddou; Biserka Relic; Olivier Malaise; Edith Charlier; Aline Desoroux; Yves Beguin; Dominique de Seny; Michel G Malaise
Journal:  Stem Cells Dev       Date:  2011-12-23       Impact factor: 3.272

10.  Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate.

Authors:  Chiara Capelli; Elisa Gotti; Marina Morigi; Cinzia Rota; Ling Weng; Francesco Dazzi; Orietta Spinelli; Giovanni Cazzaniga; Rosangela Trezzi; Andrea Gianatti; Alessandro Rambaldi; Josee Golay; Martino Introna
Journal:  Cytotherapy       Date:  2011-03-18       Impact factor: 5.414

View more
  3 in total

1.  Mesenchymal stem cells in maxillary sinus augmentation: A systematic review with meta-analysis.

Authors:  Francesco G Mangano; Marco Colombo; Giovanni Veronesi; Alberto Caprioglio; Carlo Mangano
Journal:  World J Stem Cells       Date:  2015-07-26       Impact factor: 5.326

2.  Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction.

Authors:  Arantxa Blázquez-Prunera; José María Díez; Rodrigo Gajardo; Salvador Grancha
Journal:  Stem Cell Res Ther       Date:  2017-04-27       Impact factor: 6.832

3.  A novel method to isolate mesenchymal stem cells from mouse umbilical cord.

Authors:  Bin Zhang; Jie Zhang; Hui Shi; Fei Mao; Juanjuan Wang; Yongmin Yan; Xu Zhang; Hui Qian; Wenrong Xu
Journal:  Mol Med Rep       Date:  2017-11-03       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.